An editorial criticizes the administration’s response to coronavirus disease 2019 (COVID-19); the National Cancer Institute announces an antibody testing network; 39 states see rises in COVID-19 cases.
In an editorial published in The New England Journal of Medicine (NEJM), 34 editors called out the Trump administration’s mishandling of the coronavirus disease 2019 (COVID-19) pandemic, stating leaders have “taken a crisis and turned it into a tragedy.” Although it is not an explicit endorsement of former Vice President Joe Biden, the article marks the first time NEJM has supported or condemned a political candidate in its 208-year, largely nonpartisan history, The New York Times reports. The editorial comes as 2 other leading medical publications, The Lancet and Science Magazine, recently released similar articles critical of the president’s handling of the pandemic.
The National Cancer Institute (NCI) announced its new Serological Sciences Network for COVID-19 (SeroNet), which aims to study the immune response to COVID-19. SeroNet will be the nation’s largest coordinated effort to combat the pandemic by improving the ability to test for infections and speed the development of treatments and vaccines, the announcement says. Twenty-five of the nation’s top biomedical research institutions will receive grants from the program. Using funds from an emergency appropriation of $306 million to NCI, the network aims to develop, validate, and improve serological testing.
Nine months into the pandemic, 39 states report they are seeing a rise in COVID-19 cases as the nation’s total cases surpassed 7.5 million on October 7. Nine states—Alaska, Indiana, Kansas, Kentucky, Minnesota, Montana, North Dakota, Utah, and Wyoming—have also recently set 7-day records for infections, USA Today reports. Wisconsin and Hawaii reported record numbers of deaths in their states in the last 7-day period. Wisconsin health officials announced that a field hospital is expected to open on October 14 to treat the surge in cases threatening to overwhelm hospitals.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More